NCT02924324View on ClinicalTrials.gov

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Neuroblastoma
Interventions
DEVICE

propofol

DRUG

ropivacaine

BEHAVIORAL

Wong-Baker FACES® Pain Rating Scale

Nurses will record patient-reported pain scores.

BEHAVIORAL

Post-procedural quality of life (QOL)

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02924324 - Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients | Biotech Hunter | Biotech Hunter